Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

2yrs ago Cannabis greenmarketreport Views: 400

-

It’s time for your Daily Hit of cannabis financial news for September 2, 2021.

On the Site

Forian

Healthcare tech company Forian Inc. (NASDAQ: FORA) has raised $24 million through a convertible note offering. The company said in a statement that the notes are convertible into shares of the company’s common stock at a conversion price of $11.98, the consolidated closing bid price of its common stock as reported by the Nasdaq on Tuesday, August 31, 2021. In addition to the fundraising, Forian appointed Michael Vesey as Chief Financial Officer effective September 2, 2021. Vesey will succeed Clifford Farren, who will remain with Forian in an advisory capacity through the end of the year to ensure an orderly transition.

Beverages

The global cannabis beverage market is estimated to reach $2.8 billion by 2025 and is projected to see a growth rate of 17.8% from 2019 to 2025. As consumer behavior shifts from carbonated soft drinks to health sodas and legalization gains more footholds across the country, the cannabis beverage market pivots to offer consumers potent and flavor-forward beverages that offer a fresh take on the time-honored ritual of “kicking back with a cold one”. Innovative technologies are likewise flourishing, a development that both drives and responds to growth in the cannabis beverages market.

NY

Green Market Report broke the news yesterday that New York’s Governor Kathy Hochul had named her two candidates for leading the adult-use cannabis legalization movement. Chris Alexander for the Executive Director of the Office of Cannabis Management and Tremaine Wright will be named Chair of the Board. Late Wednesday the state Senate confirmed both nominees to lead the agencies that will regulate cannabis sales in New York. The process had stalled under Governor Cuomo who publicly supported legalization, but often stalled the process behind the scenes.

 

In Other News

 

Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) has received approval from the Florida Department of Health’s Office of Medical Marijuana Use (OMMU) to operate as Cannabist.

Effective immediately, Columbia Care’s 14 dispensary locations across the state will be renamed to Cannabist. Patients will continue to have access to the same high-quality cannabis products at their preferred dispensaries and will begin seeing retail improvements that reflect the new Cannabist brand and shopping experience.

The Daily Cannabis Hit on Green Market Report.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.